Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Added to Russell 2000, 3000 Indexes

NEW YORK, July 6 (GenomeWeb News) - Strategene was added late last month to the Russell 3000 and Russell 2000 indexes, the La Jolla, Calif.-based life sciences firm said today.

 

Russell, an investment strategies firm, measures the performance of the 3,000 largest US companies with its 3000 index, as well as the 2,000 smallest companies with its 2000 index, both of which are based on market capitalization.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.